# Qingran Yan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qingran-yan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 734 |
| Field | Systemic Sclerosis and Related Diseases |
| h-index | 15 |
| i10-index | 21 |
| Last Known Institution | China Pharmaceutical University |
| OpenAlex ID | https://openalex.org/A5038238118 |
| ORCID iD | 0000-0002-2781-5280 |
| Works | 61 |

## Researcher papers

- [Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis](https://scholariq.org/papers/iguratimod-represses-b-cell-terminal-differentiation-linked-with-the-inhibition/)
- [Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover](https://scholariq.org/papers/endometrial-cancer-associated-mutants-of-spop-are-defective-in-regulating/)
- [Targeting miR-155 to Treat Experimental Scleroderma](https://scholariq.org/papers/targeting-mir-155-to-treat-experimental-scleroderma/)
- [Laparoscopically assisted sigmoid colon vaginoplasty in women with Mayer–Rokitansky–Kuster–Hauser syndrome: feasibility and short‐term results](https://scholariq.org/papers/laparoscopically-assisted-sigmoid-colon-vaginoplasty-in-women-with-mayer/)
- [Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis](https://scholariq.org/papers/aberrant-activation-of-the-wnt-catenin-signaling-pathway-in-lupus-nephritis/)
- [High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center](https://scholariq.org/papers/high-incidence-and-mortality-of-pneumocystis-jirovecii-infection-in-anti-mda5/)
- [Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice](https://scholariq.org/papers/prevention-of-immune-nephritis-by-the-small-molecular-weight-immunomodulator/)
- [Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis](https://scholariq.org/papers/endothelial-response-to-type-i-interferon-contributes-to-vasculopathy-and/)
- [Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus](https://scholariq.org/papers/tailoring-the-treatment-of-inflammatory-rheumatic-diseases-by-a-better/)
- [Investigating the role of angiogenesis in systemic lupus erythematosus](https://scholariq.org/papers/investigating-the-role-of-angiogenesis-in-systemic-lupus-erythematosus/)
- [Dihydroartemisinin alleviates skin fibrosis and endothelial dysfunction in bleomycin-induced skin fibrosis models](https://scholariq.org/papers/dihydroartemisinin-alleviates-skin-fibrosis-and-endothelial-dysfunction-in/)

## Researcher topics

- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Dermatologic Treatments and Research](https://scholariq.org/topics/dermatologic-treatments-and-research/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)

## Researcher university

- [China Pharmaceutical University](https://scholariq.org/institutions/china-pharmaceutical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.